Dysregulation of miR-122, miR-574 and miR-375 in Egyptian patients with breast cancer.
Eman A ElghorouryEsmat E AbdelghafarSolaf KamelEman AwadallahAliaa ShalabyGamila S M El-SaeedEman MahmoudMahmoud M KamelAsmaa AbobakrRasha Nazih YousefPublished in: PloS one (2024)
Our findings suggest that miR-122 may act as an onco-microRNA, while miR-574 and miR-375 may have a main tumour suppressor role. The studied miRNAs may serve as minimally invasive biomarkers for cases of breast cancer and as promising potential therapeutic targets for breast cancer.